vs
Side-by-side financial comparison of AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
SELECT MEDICAL HOLDINGS CORP is the larger business by last-quarter revenue ($1.4B vs $1.4B, roughly 1.0× AMERICAN AXLE & MANUFACTURING HOLDINGS INC). SELECT MEDICAL HOLDINGS CORP runs the higher net margin — 1.4% vs -5.4%, a 6.9% gap on every dollar of revenue. On growth, SELECT MEDICAL HOLDINGS CORP posted the faster year-over-year revenue change (6.4% vs 0.2%). AMERICAN AXLE & MANUFACTURING HOLDINGS INC produced more free cash flow last quarter ($54.7M vs $5.2M). Over the past eight quarters, SELECT MEDICAL HOLDINGS CORP's revenue compounded faster (2.8% CAGR vs -7.2%).
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
AXL vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.4B |
| Net Profit | $-75.3M | $20.2M |
| Gross Margin | 10.2% | — |
| Operating Margin | -2.4% | 4.6% |
| Net Margin | -5.4% | 1.4% |
| Revenue YoY | 0.2% | 6.4% |
| Net Profit YoY | -449.6% | 225.7% |
| EPS (diluted) | $-0.62 | $0.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.4B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.4B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.6B | $1.3B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | $-75.3M | $20.2M | ||
| Q3 25 | $9.2M | $28.8M | ||
| Q2 25 | $39.3M | $40.6M | ||
| Q1 25 | $7.1M | $56.7M | ||
| Q4 24 | $-13.7M | $-16.1M | ||
| Q3 24 | $10.0M | $55.6M | ||
| Q2 24 | $18.2M | $77.6M | ||
| Q1 24 | $20.5M | $96.9M |
| Q4 25 | 10.2% | — | ||
| Q3 25 | 12.6% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | 13.3% | — | ||
| Q1 24 | 12.4% | — |
| Q4 25 | -2.4% | 4.6% | ||
| Q3 25 | 3.2% | 5.4% | ||
| Q2 25 | 3.6% | 6.5% | ||
| Q1 25 | 3.0% | 8.3% | ||
| Q4 24 | 2.6% | 1.6% | ||
| Q3 24 | 2.8% | 4.3% | ||
| Q2 24 | 5.3% | 5.8% | ||
| Q1 24 | 4.8% | 9.0% |
| Q4 25 | -5.4% | 1.4% | ||
| Q3 25 | 0.6% | 2.1% | ||
| Q2 25 | 2.6% | 3.0% | ||
| Q1 25 | 0.5% | 4.2% | ||
| Q4 24 | -1.0% | -1.2% | ||
| Q3 24 | 0.7% | 4.4% | ||
| Q2 24 | 1.1% | 6.1% | ||
| Q1 24 | 1.3% | 7.3% |
| Q4 25 | $-0.62 | $0.17 | ||
| Q3 25 | $0.07 | $0.23 | ||
| Q2 25 | $0.32 | $0.32 | ||
| Q1 25 | $0.06 | $0.44 | ||
| Q4 24 | $-0.11 | $-0.12 | ||
| Q3 24 | $0.08 | $0.43 | ||
| Q2 24 | $0.15 | $0.60 | ||
| Q1 24 | $0.17 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $708.9M | $26.5M |
| Total DebtLower is stronger | $4.0B | $1.8B |
| Stockholders' EquityBook value | $640.0M | $1.7B |
| Total Assets | $6.7B | $5.9B |
| Debt / EquityLower = less leverage | 6.31× | 1.06× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $708.9M | $26.5M | ||
| Q3 25 | $714.1M | $60.1M | ||
| Q2 25 | $586.5M | $52.3M | ||
| Q1 25 | $549.2M | $53.2M | ||
| Q4 24 | $552.9M | $59.7M | ||
| Q3 24 | $542.5M | $191.5M | ||
| Q2 24 | $519.9M | $111.2M | ||
| Q1 24 | $469.8M | $92.6M |
| Q4 25 | $4.0B | $1.8B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.8B | ||
| Q1 25 | $2.6B | $1.8B | ||
| Q4 24 | $2.6B | $1.7B | ||
| Q3 24 | $2.6B | $3.1B | ||
| Q2 24 | $2.7B | $3.6B | ||
| Q1 24 | $2.7B | $3.8B |
| Q4 25 | $640.0M | $1.7B | ||
| Q3 25 | $718.4M | $1.7B | ||
| Q2 25 | $673.0M | $1.7B | ||
| Q1 25 | $596.3M | $1.7B | ||
| Q4 24 | $562.8M | $1.7B | ||
| Q3 24 | $616.3M | $1.9B | ||
| Q2 24 | $609.6M | $1.4B | ||
| Q1 24 | $621.4M | $1.4B |
| Q4 25 | $6.7B | $5.9B | ||
| Q3 25 | $5.3B | $5.7B | ||
| Q2 25 | $5.3B | $5.7B | ||
| Q1 25 | $5.1B | $5.7B | ||
| Q4 24 | $5.1B | $5.6B | ||
| Q3 24 | $5.3B | $8.0B | ||
| Q2 24 | $5.3B | $7.9B | ||
| Q1 24 | $5.4B | $7.9B |
| Q4 25 | 6.31× | 1.06× | ||
| Q3 25 | 3.61× | 1.03× | ||
| Q2 25 | 3.86× | 1.10× | ||
| Q1 25 | 4.38× | 1.03× | ||
| Q4 24 | 4.58× | 1.01× | ||
| Q3 24 | 4.28× | 1.62× | ||
| Q2 24 | 4.42× | 2.54× | ||
| Q1 24 | 4.40× | 2.75× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.5M | $64.3M |
| Free Cash FlowOCF − Capex | $54.7M | $5.2M |
| FCF MarginFCF / Revenue | 4.0% | 0.4% |
| Capex IntensityCapex / Revenue | 4.8% | 4.2% |
| Cash ConversionOCF / Net Profit | — | 3.19× |
| TTM Free Cash FlowTrailing 4 quarters | $155.1M | $117.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.5M | $64.3M | ||
| Q3 25 | $143.3M | $175.3M | ||
| Q2 25 | $91.9M | $110.3M | ||
| Q1 25 | $55.9M | $-3.5M | ||
| Q4 24 | $151.2M | $125.4M | ||
| Q3 24 | $143.6M | $181.0M | ||
| Q2 24 | $142.8M | $278.2M | ||
| Q1 24 | $17.8M | $-66.7M |
| Q4 25 | $54.7M | $5.2M | ||
| Q3 25 | $79.2M | $122.2M | ||
| Q2 25 | $34.6M | $45.6M | ||
| Q1 25 | $-13.4M | $-55.8M | ||
| Q4 24 | $73.2M | $62.0M | ||
| Q3 24 | $70.4M | $130.3M | ||
| Q2 24 | $94.0M | $222.6M | ||
| Q1 24 | $-30.2M | $-119.2M |
| Q4 25 | 4.0% | 0.4% | ||
| Q3 25 | 5.3% | 9.0% | ||
| Q2 25 | 2.3% | 3.4% | ||
| Q1 25 | -0.9% | -4.1% | ||
| Q4 24 | 5.3% | 4.7% | ||
| Q3 24 | 4.7% | 10.2% | ||
| Q2 24 | 5.8% | 17.4% | ||
| Q1 24 | -1.9% | -9.0% |
| Q4 25 | 4.8% | 4.2% | ||
| Q3 25 | 4.3% | 3.9% | ||
| Q2 25 | 3.7% | 4.8% | ||
| Q1 25 | 4.9% | 3.9% | ||
| Q4 24 | 5.6% | 4.8% | ||
| Q3 24 | 4.9% | 4.0% | ||
| Q2 24 | 3.0% | 4.3% | ||
| Q1 24 | 3.0% | 4.0% |
| Q4 25 | — | 3.19× | ||
| Q3 25 | 15.58× | 6.09× | ||
| Q2 25 | 2.34× | 2.72× | ||
| Q1 25 | 7.87× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | 14.36× | 3.25× | ||
| Q2 24 | 7.85× | 3.59× | ||
| Q1 24 | 0.87× | -0.69× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
